Plenary and Keynote Speakers
9th International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering (NDDTE 2024)
We are pleased to announce our plenary and keynote speakers for 9th International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering (NDDTE 2024):
Dr. Diane Burgess
University of Connecticut, USA
Plenary Speaker
Diane J. Burgess, Ph.D. Distinguished Professor, Pfizer Distinguished Chair in Pharmaceutical Technology, University of Connecticut.
B.Sc. Pharmacy, University of Strathclyde (1979) and Ph.D. Pharmaceutics, University of London (1984). Fellow of AAPS, CRS, APSTJ, AIMBE and the National Academy of Inventors. 2010 CRS President; 2002 AAPS President. Editor of International Journal of Pharmaceutics (2009 – 2018). Editorial board member of 13 international journals. Recipient of: 2023 AAPS Alice E. Till Advancement of Women in Pharmaceutical Sciences Recognition; 2023 University of Connecticut AAUP Edward C. Marth Mentorship Award; 2018 AAPS Wurster Award in Pharmaceutics; 2014 AAPS Research Achievement Award; 2014 AAPS Outstanding Educator Award; 2014 CRS Distinguished Service Award; 2013 AAPS IPEC Ralph Shangraw Award; 2010 CRSI Fellowship, 2011 APSTJ Nagai International Woman Scientist Award. Over 280 refereed publications, over 730 research presentations, over 342 invited presentations, 29 keynote and plenary addresses.
Founder, DIANT Pharma (2019). DIANT Pharma develops proprietary continuous manufacturing technology for nanoparticles with a wide array of applications throughout multiple industries, such as lipid nanoparticles and liposomes for pharmaceutical formulations.
Inventor on 14 patents/patent applications, eleven of which have been licensed to companies and five products/product lines have already been commercialized.
Topic of Keynote: Continuous Manufacturing of Complex Parenterals such as mRNA Vaccines and Liposomes
Plenary Abstract
Dr. Moein Moghimi
Newcastle University, UK
Plenary Speaker
Moein Moghimi is a Professor of Pharmaceutics and Nanomedicine at the School of Pharmacy, and Translational and Clinical Research Institute, Newcastle University (UK), and an Adjoint Professor at the Skaggs School of Pharmacy, University of Colorado, Denver. He is co-founder of S M Discovery Group Inc. and S M Discovery Group Ltd. He further serves as an Associate Editor of Molecular Therapy (the flagship journal of the American Society of Gene Therapy) and Drug Delivery (Taylor and Francis). Previously, he was Chair of Nanomedicine at Durham University (UK), Professor of Nanomedicine at Copenhagen University, Director of the Centre for Pharmaceutical Nanotechnology and Nanotoxicology (Copenhagen University), Visiting Professor at the University of Padova (Italy) and Affiliate Professor at Houston Methodist Research Institute (Texas). He graduated with Honors in Biochemistry from the University of Manchester (UK) in 1985 and completed his PhD in Biochemistry at Charing Cross and Westminster Medical School (Imperial College). He is widely published and reported in the press, and recognised for his contribution to fundamental and translational research in nanomedicine and drug delivery, especially in mechanistic understanding of nanoparticle-mediated adverse reactions and complement activation processes, and as an inventor of many tissue-specific drug delivery systems and therapeutic platforms (e.g., NanoLigand Carriers for crossing the blood-brain barrier and targeting neurons and microglial cells). A 2021 study conducted by Stanford University list Moghimi among the top 0.1% of world’s leading scientists across in all fields, and top 60 in pharmacology in the world.
Topic of Keynote: Nanomedicine: A New Frontier in Precision Medicine
Plenary Abstract
Dr. Manuela Calin
Institute of Cellular Biology and Pathology, Romanian Academy of Sciences, Romania
Keynote Speaker
Dr. Manuela Călin studied Physics at the University of Bucharest and graduated with an M.S. in Biophysics in 1996. She then joined the research group of the Institute of Cellular Biology and Pathology “N. Simionescu”, Bucharest where she received her Ph.D. degree in Biological Sciences in 2005 under the supervision of Dr. Maya Simionescu. Then she performed a 3-year post-doc in “Biomaterials: nanocarriers for controlled drug release” at the Institute of Macromolecular Chemistry “Petru Poni”, Iasi, Romania. She received her Habilitation degree in Biology and Biochemistry in 2021. She is currently a scientific researcher grade I, head of the “Medical and Pharmaceutical BioNanoTechnologies” laboratory, and a member of the Scientific Council of the Institute of Cellular Biology and Pathology “N. Simionescu”. Her research interests lie within the field of Nanomedicine and are focused on the development of new and effective targeted drug delivery systems based on nanoparticles for cardiovascular diseases treatment. She received ten national and international prizes, and published 55 papers in ISI journals, cited >1700 times, h-index: 25 (as per Google Scholar).
Topic of Keynote: Nanotherapeutic Strategies to Reduce Vascular Inflammation in Cardiovascular Diseases
keynote Abstract
Dr. Martin Pisarcik
Comenius University, Slovakia
Keynote Speaker
Assoc. prof. Martin Pisárčik graduated at the Slovak University of Technology, Faculty of Electrical Engineering, Bratislava, Slovakia (1987), in the field of solid state physics. He received his PhD from the Slovak University of Technology, Faculty of Chemical Technology (1992) in the field of technology of macromolecular compounds. He obtained his habilitation degree in the same professional field at the Slovak University of Technology, Faculty of Chemical and Food Technology (2009). Currently, he is the head of Department of Chemical Theory of Drugs at the Faculty of Pharmacy of Comenius University in Bratislava. His expert background and scientific interests are focused on novel amphiphilic molecules with distinct biological activity and synthesis and physical investigations of bioactive metal nanoparticles.
Topic of Keynote: Cationic Gemini Surfactants as Efficient Capping Agents of Silver And Gold Nanoparticles
Keynote Abstract
Dr. Giovanni Tosi
University of Modena and Reggio Emilia, Italy
Keynote Speaker
Since November 2005, Dr. Giovanni Tosi is researcher in the scientific field of Pharmaceutical Technology at the University of Modena and Reggio Emilia (PI at the department of Pharmaceutical Sciences, which belongs to the faculty of Pharmacy). Since 2015, he is associate professor in the same field. He got certificate for Full professor in 2017, and now he is full Professor since 2020.He was born in 1977 (March, 2nd) in Bologna, Italy, and got his degree in Pharmacy in 2002 with 110/110. He got his PhD in Pharmaceutical Sciences in 2005 at the University of Modena and Reggio Emilia, Italy. He was Coordinator of “Applied Technology” curricula for the PhD school in Health Products, member of Instruments Commission of Dep.Pharm.Sci., Contact Person ILO of Dep.Pharm.Sci, Research products, Representative of the Dep.Pharm.Sci. in the Central Board of Animal House and Committee for Research of University of Modena and Reggio Emilia. He now director of Hospital Pharmacy Specialization Programme and coordinator of KETs National Center for RNA drugs in Rare Diseases Spoke.
He is scientific delegate for international cooperation and coordinator of UNIMORE Nanomedicine Platform since 2017 and vice-chair of WG Nanotherapeutics in European Technology Platform for Nanomedicine since 2019 and now secretary of ETPN. The research activity is based on the development of lipid and polymeric systems for the delivery and the targeting of drugs to diseased tissues or cells. His works on nanomedicine for drug and gene delivery and targeting were honored with national prices and awards (La Manna Prize for Student Thesis he drived), Jorge Heller Oustanding Paper Award, 2005) and Innovation price (AFI2005, AFI 2006). His work on Nanoparticles for CNS drug delivery has been recently awarded as one of the Hot Topic (150 selected research over 19.000 proposals) at the World Neuroscience Meeting (Society for Neuroscience) in Washington DC, November 2011 and World Neuroscience Meeting (Society for Neuroscience) in New Orleans, November 2012. He is author or co-author of more than 100 publications in international journals and gave over 200 presentations (invited speaker, oral presentations and posters) in international and national congresses. He participated as collaborator or project leader in several Italian and International projects supported by the Italian Research Ministry, IMI project, Euronanomed grant, Ministry of International Cooperation Projects and POR FESR project. He is now collaborating with a broad network of scientists in the field confirmed by the international participation to publications and many national and international industries (Chiesi, Pfizer, Sanofi, Gilead Sciences, Biomarin). He currently acts as referee for the top journals in nanotechnology and nanomedicine such as Journal of Controlled Release, Biomaterial, Nanomedicine and many other journals dealing with Nanotechnology, Drug Delivery and Nanomedicine.He is Member of the Editorial Advisory Board of a number of international journals.
Topic of Keynote: Nanomedicine hype: from Covid to Brain Diseases Keynote Abstract
Important information for accompanying person(s): Please be informed that the accompanying person can NOT be a co-author.
Co-authors, regardless if 1 author is attending, must pay the full registration fee.
The accompany person fee is only for spouses and/or children. Please contact us if you are unsure.
Registration fee includes the following:
- Publication of 1 accepted paper in the proceedings. Publication of each additional paper requires a €250 EUR registration
- Buffet lunch for each day of the conference
- 2 coffee breaks for each day of the conference
- 1 banquet dinner OR cruise tour
Virtual registration fee includes the following:
- Publication of 1 accepted paper in the proceedings. Publication of each additional paper requires a €150 EUR registration
- Access to all the sessions of the conference